JANUS BIOTHERAPEUTICS, INC.

Profile

Company Names

JANUS BIOTHERAPEUTICS, INC.

Addresses

65 WILLIAM STREET, SUITE 200, WELLESLEY, MA 02481

888 WORCESTER STREET, SUITE 95, WELLESLEY, MA 02482

222 THIRD STREET, SUITE 2240, CAMBRIDGE, MA 02142

Phone Numbers

781-705-3024
617-225-7700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$2,268,228.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-07-16 
$668,228.00 
$4,000,000.00 
$3,331,772.00 
Equity 
2
2011-08-15 
$1,100,000.00 
$3,000,000.00 
$1,900,000.00 
Equity 
1
2011-01-17 
$500,000.00 
$3,000,000.00 
$2,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
 
BARON 
EXECUTIVE OFFICER, DIRECTOR
JANUS BIOTHERAPEUTICS, INC.   |  CENSA PHARMACEUTICALS INC.   |  INTERA ONCOLOGY INC.   |  65BIO INC.   |  ATACAMA THERAPEUTICS, INC.
STEVEN 
 
BERNITZ 
DIRECTOR
JANUS BIOTHERAPEUTICS, INC.
CHRISTINE 
 
DE LOS REYES 
DIRECTOR
COGNOPTIX, INC.   |  JANUS BIOTHERAPEUTICS, INC.
GRAYSON 
 
LIPFORD 
EXECUTIVE OFFICER, DIRECTOR
JANUS BIOTHERAPEUTICS, INC.
JONATHAN 
 
REIS 
DIRECTOR
CENSA PHARMACEUTICALS INC.   |  INTERA ONCOLOGY INC.   |  JANUS BIOTHERAPEUTICS, INC.   |  65BIO INC.   |  ATACAMA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-08-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-16 
2011-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-15 
2011-03-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#